NEW YORK — Americans who have received Pfizer vaccinations are eager for a booster shot. Millions of people who have received the Moderna and Johnson & Johnson vaccines are waiting to find out when their turn comes.
The federal regulators are beginning to tackle this issue this week. The Food and Drug Administration will convene its independent advisors on Thursday and Friday to decide whether additional shots of the vaccines should be given and, if yes, when and who.
At most, the final go-ahead will not be given until at least week. The FDA advisors will present their recommendations and the agency will then make an official decision about authorizing boosters. A panel that is chaired by the Centers for Disease Control and Prevention (CDC) will then provide more details about who should receive them.
The FDA meetings occur as U.S. vaccinations are back above 1,000,000 per day, an increase more than half in the past week. This rise is primarily due to Pfizer boosters, and employer mandates for vaccines.